|
J. Biol. Chem., Vol. 265, Issue 14, 8198-8204, May, 1990
Alveolar epithelial cell plasminogen activator. Characterization and regulation
BC Marshall, DS Sageser, NV Rao, M Emi and JR Hoidal
Department of Human Genetics, University of Utah Medical Center, Salt Lake City 84132.
Intra-alveolar fibrin deposition is one of the pathological hallmarks of
acute lung injury. Because alveolar epithelial cells play a central role in
the repair process following acute lung injury, this study was undertaken
to examine their potential to produce a plasminogen activator (PA). We now
report the synthesis and secretion of PA by rat alveolar epithelial cells
with the catalytic properties of a urokinase- type (u-PA) rather than
tissue-type plasminogen activator. Studies of regulation of epithelial cell
u-PA revealed: 1) phorbol myristate acetate (PMA) but not the inactive
structural analog 4 alpha-PMA upregulated u-PA synthesis, putatively via
the protein kinase C pathway; 2) PMA induction of u-PA activity was
substantially inhibited by dexamethasone and completely inhibited by
cycloheximide; 3) unstimulated alveolar epithelial cells had no detectable
u-PA mRNA, whereas PMA exposure led to activation of the u-PA gene and
accumulation of a 2.5-kilobase u-PA mRNA; and 4) cycloheximide did not
abolish this induction of u-PA mRNA suggesting that intermediate protein
synthesis was not necessary for the activation of transcription. In light
of their capacity to promote fibrinolysis and their strategic anatomic
location, alveolar epithelial cells are likely to play a key role in the
extensive remodelling process that follows acute lung injury.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. J Schultz and M. Levi
Pulmonary coagulopathy: a potential therapeutic target in different forms of lung injury
Thorax,
July 1, 2007;
62(7):
563 - 564.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Nishiuma, T. H. Sisson, N. Subbotina, and R. H. Simon
Localization of Plasminogen Activator Activity within Normal and Injured Lungs by In Situ Zymography
Am. J. Respir. Cell Mol. Biol.,
November 1, 2004;
31(5):
552 - 558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. B. Ware and M. A. Matthay
Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair
Am J Physiol Lung Cell Mol Physiol,
May 1, 2002;
282(5):
L924 - L940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. DOHI, T. HASEGAWA, K. YAMAMOTO, and B. C. MARSHALL
Hepatocyte Growth Factor Attenuates Collagen Accumulation in a Murine Model of Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
December 1, 2000;
162(6):
2302 - 2307.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Hasegawa, L. Sorensen, H. Ooi, and B. C. Marshall
Decreased Intracellular Iron Availability Suppresses Epithelial Cell Surface Plasmin Generation . Transcriptional and Post-transcriptional Effects on u-PA and PAI-1 Expression
Am. J. Respir. Cell Mol. Biol.,
August 1, 1999;
21(2):
275 - 282.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Takahashi, Y. Uwabe, Y. Sawasaki, T. Kiguchi, H. Nakamura, K. Kashiwabara, H. Yagyu, and T. Matsuoka
Increased secretion of urokinase-type plasminogen activator by human lung microvascular endothelial cells
Am J Physiol Lung Cell Mol Physiol,
July 1, 1998;
275(1):
L47 - L54.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. van Dam, S. Huguier, K. Kooistra, J. Baguet, E. Vial, A. J. van der Eb, P. Herrlich, P. Angel, and M. Castellazzi
Autocrine growth and anchorage independence: two complementing Jun-controlled genetic programs of cellular transformation
Genes & Dev.,
April 15, 1998;
12(8):
1227 - 1239.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
W. L. Simmons, K. E. Rivera, D. T. Curiel, W. F. Williams, and M. A. Olman
Adenovirally Mediated Gene Transfer of Functional Human Tissue-type Plasminogen Activator to Murine Lungs
Am. J. Respir. Cell Mol. Biol.,
March 1, 1998;
18(3):
307 - 314.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S Stefansson, M. Kounnas, J Henkin, R. Mallampalli, D. Chappell, D. Strickland, and W. Argraves
gp330 on type II pneumocytes mediates endocytosis leading to degradation of pro-urokinase, plasminogen activator inhibitor-1 and urokinase-plasminogen activator inhibitor-1 complex
J. Cell Sci.,
January 6, 1995;
108(6):
2361 - 2368.
[Abstract]
[PDF]
|
 |
|
Copyright © 1990 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|